Raleigh’s Inceptor Bio raises $37.7M, could raise more than $60M

RALEIGH – The Raleigh-based biotechnology startup Inceptor Bio disclosed on Friday in an SEC filing that it has raised more than $37.7 million in equity from nine investors.

The cell and gene therapy company, which seeks to “address the major challenges in oncology,” according to the firm’s website, could raise more than $60 million, according to the filing.

WRAL TechWire reported in October 2021 that the company had made an acquisition of a Florida-based company, which included some 29,000 square feet of manufacturing space in a facility in the Gainesville area, and had raised some $26 million from the Kineticos Disruptor Fund.

The filing notes a current disclosed total of $37,731,621 from nine investors, and was filed on March 4, 20222. According to the filing, the round could grow to be as high as $60,811,621.

The company has not yet responded to a request for comment on this story. WRAL TechWire profiled the company in June 2021.